Non-nucleoside reverse transcriptase inhibitors
AssigneeBoehringer Ingelheim International GmbH
InventorsJeffrey O'Meara, Bruno Simoneau, Christiane Yoakim, Robert Deziel, William W. Ogilvie
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of formula I: 1 wherein R2 is H, halogen, (C1-4)alkyl, O(C1-4)alkyl, NH(C1-4alkyl) or N(C1-4alkyl)2; R4 is H or CH3; R5 is H or CH3; R12 is H, halogen, (C1-4)alkyl, CF3, or NO2; R13 is H, (C1-4)alkyl, halogen, OH, or NH2, with the proviso that R12 and R13 are not both H; and R14 is COOR14a wherein R14a is H or (C1-6)alkyl; or R14 is (C2-4)alkenyl-COOR14a wherein R14a is as defined herein; or R14 is (C1-4)alkyl-COOR14a wherein R14a is as defined above; or a salt or a prodrug thereof, useful as inhibitors of HIV reverse transcriptase.
Claims23
A compound of formula I:
- 15
- wherein
- R2 is H, halogen, (C1-4)alkyl, O(C1-4)alkyl, NH(C1-4alkyl) or N(C1-4alkyl)2;
- R4 is H or CH3;
- R5 is H or CH3, provided that R4 and R5 are not both the same;
- R12 is H, halogen, (C1-4)alkyl, CF3, or NO2;
- R13 is H, (C1-4)alkyl, halogen, OH, or NH2, with the proviso that R12 and R13 are not both H;
- and
- R14 is COOR14a wherein R14a is H or (C1-6)alkyl;
- or R14 is (C2-4)alkenyl-COOR14a wherein R14a is as defined herein;
- or R14 is (C1-4)alkyl-COOR14a wherein R14a is as defined above;
- or a salt or a prodrug thereof:
Dependencies are inferred from the claim text.